[1]薛天祺,路 云,常 峰.国家药品集中带量采购中选结果及采购规则优化方向分析[J].卫生经济研究,2022,39(5):12-16.
　XUE Tian-qi,LU Yun,CHANG Feng.Analysis of Selected Results and Rule Optimization Direction of National Pharmaceutical Centralized Volume-Based Procurement[J].Journal Press of Health Economics Research,2022,39(5):12-16.
点击复制

国家药品集中带量采购中选结果及采购规则优化方向分析
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
39
期数:
2022年5期
页码:
12-16
栏目:
药械管理
出版日期:
2022-04-27

文章信息/Info

Title:
Analysis of Selected Results and Rule Optimization Direction of National Pharmaceutical Centralized Volume-Based Procurement
作者:
薛天祺1; 路 云1; 常 峰1
1.中国药科大学国际医药商学院，江苏 南京 211198
Author(s):
XUE Tian-qi;  LU Yun;  CHANG Feng
School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing Jiangsu 211198, China
关键词:
药品集中采购; 带量采购; 中选结果; 规则优化
Keywords:
pharmaceutical centralized volume-based procurement;  volume-based procurement;  selection result;  rule optimization
分类号:
R19
文献标志码:
A
摘要:
我国药品集中带量采购工作在常态化制度化推进的同时，采购范围由化学药扩展至生物药，采购规则逐批优化，配套措施逐渐完善。本文对各批次国家药品集中带量采购的中选结果、采购规则及优化方向进行对比分析，为进一步推动改革，最终形成竞争充分、价格合理、规范有序的药品供应保障体系提供思路。
Abstract:
With the normalized and institutionalized pharmaceutical centralized volume-based procurement advancing in China, drug procurement scope has been expanded from chemical drugs to biological drugs, beneficial experience has been accumulated, procurement policies have been optimized, supporting measures have been improved, and the reform of medical and health system has achieved obvious results. This paper researched the application information and selected results of six batch (seven time) national pharmaceutical centralized procurement, and summarized the optimization direction of volume-based procurement rules. This paper provides ideas for volume-based procurement, in order to make it play more roles in guiding drug prices to return to the reasonable level, improving people's well-being and promoting industry development.

参考文献/References:

[1] 王东进.关于药品医用耗材集中带量采购的思考[J].中国医疗保险，2020（8）：1-3.
[2] 徐源，何江江，陈珉惺，等.药品集中采购国际经验及对我国国家层面带量采购的启示[J].中国卫生经济，2021，40（4）：93-96.
[3] Maniadakis Nikolaos，Holtorf Anke-Peggy，Otávio Corrêa José，Gialama Fotini，Wijaya Kalman. Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage[J].Applied Health Economics and Health Policy，2018，16（5）.
[4] 冯海宁.药品集中采购何以节约2500亿元[N].中国劳动保障报，2021-11-12（008）.
[5] 王超.公共支出背景下药品采购费用控制研究[J].合作经济与科技，2021（24）：164-165.
[6] Inotai Andras，Brixner Diana，Maniadakis Nikos，et al. Development of multi-criteria decision analysis （MCDA） framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia[J].BMC health services research，2018，18（1）.
[7] 常峰.药品带量采购的核心要素分析[J].中国卫生资源，2021，24（1）：15-19.
[8] Simona Baldi，Davide Vannoni. The impact of centralization on pharmaceutical procurement prices：the role of institutional quality and corruption[J].Regional Studies，2015，51（3）.
[9] 李孟.平均降价56% 第五批药品集采规模创新高[N].中国商报，2021-07-06（003）.
[10] 付硕雄.基于经济学视角对我国药品集中采购改革的优势分析[J].中国集体经济，2021（34）：67-68.
[11] 胡善联.药品带量采购如何走向常态化制度化[N]. 医药经济报，2021-06-21（001）.

相似文献/References:

[1]袁 姣,刘杨正,左克源,等.基于药品集中采购的供应链融资模式研究[J].卫生经济研究,2017,(01):50.
[2]周 苑,汤质如,刘守明,等.药品集中采购模式研究及问题探讨[J].卫生经济研究,2018,(03):26.
[3]吴 天.药品集中采购价格与药品费用控制研究[J].卫生经济研究,2018,(12):32.
　WU Tian.Research on Centralized Purchasing Price and Drug Cost Control of Medicines[J].Journal Press of Health Economics Research,2018,(5):32.
[4]黎东生,白雪珊.带量采购降低药品价格的一般机理及“4+7招采模式”分析[J].卫生经济研究,2019,(08):10.
　LI Dong-sheng,BAI Xue-shan.The General Mechanism of Reducing the Price of Medicines by Quantity Purchase and the Analysis of “4+7 Recruitment Mode”[J].Journal Press of Health Economics Research,2019,(5):10.
[5]李毅仁,路 云,卢钰琼,等.帕累托改进：我国医保战略性购买的践行路径[J].卫生经济研究,2020,(10):8.
　LI Yi-ren,LU Yun,LU Yu-qiong,et al.Pareto Improvement : the Practice Path of Strategic Purchase of Medical Insurance in China[J].Journal Press of Health Economics Research,2020,(5):8.
[6]王雅洁,徐 伟,陈明艳.江苏省医用耗材带量采购的做法及实施情况分析[J].卫生经济研究,2020,(12):21.
　WANG Ya-jie,XU Wei,CHEN Ming-yan.Analysis on the Practice and Implementation of Volume-based Procurement of Medical Consumable Materials in Jiangsu Province[J].Journal Press of Health Economics Research,2020,(5):21.
[7]蒋昌松,张立强,祁 鹏,等.带量采购的部分经济学原理解析[J].卫生经济研究,2021,38(6):63.
　JIANG Chang-song,ZHANG Li-qiang,QI Peng,et al.Analysis on Some Economic Principles of Volume-based Procurement[J].Journal Press of Health Economics Research,2021,38(5):63.
[8]谭清立,周芷婷.医用耗材带量采购的医保支付政策研究[J].卫生经济研究,2021,38(11):6.
　TAN Qing-li,ZHOU Zhi-ting.Research on Medical Insurance Payment Policy for Centralized Medical Consumables Volume-based Purchasing[J].Journal Press of Health Economics Research,2021,38(5):6.
[9]张倩倩,王 颖,肖启强,等.公立医院开展高值医用耗材集中带量采购的实践探讨[J].卫生经济研究,2022,39(11):51.
　ZHANG Qianqian,WANG Ying,XIAO Qiqiang,et al.Discussion on the Practice of Centralized Volume-Based Procurement of High-Value Medical Consumables in Public Hospitals[J].Journal Press of Health Economics Research,2022,39(5):51.
[10]谭清立,梁玮琳.广东联盟中成药带量采购的问题与应对策略[J].卫生经济研究,2023,40(6):10.
　TAN Qingli,LIANG Weilin.Discussion on the Problems and Countermeasures of Volume Purchase of Chinese Patent Medicine in Guangdong Alliance[J].Journal Press of Health Economics Research,2023,40(5):10.

更新日期/Last Update: 2022-04-27